story of the week
Association Between Use of SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis
JAMA 2018 Apr 17;319(15)1580-1591, SL Zheng, AJ Roddick, R Aghar-Jaffar, MJ Shun-Shin, D Francis, N Oliver, K MeeranFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.